
Abirawin 250 250mg
Marketer
Axiommax Oncology Pvt Ltd
Salt Composition
Abiraterone Acetate (250mg)
Overview Abirawin 250 250mg
ProstaGen 250 (250mg) is indicated for prostate cancer treatment. Its use may extend to other conditions at your physician's discretion, sometimes as part of a broader chemotherapy regimen. ProstaGen 250 should not be administered on an empty stomach; ingestion with food may induce adverse effects. Dosage and frequency are determined by your doctor, depending on your condition and may vary over time. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to serious consequences. Therapeutic effects may take weeks or months to manifest; do not discontinue use unless directed by your physician. Common side effects include nausea, hypokalemia, edema, leukopenia, and tiredness. Report any concerning symptoms to your doctor; management strategies may be available. Less frequent but serious side effects including jaundice, anorexia, dyspnea, dark urine, and nausea, can suggest liver complications. Your doctor may monitor liver function, blood pressure, and potassium levels. Prior to commencing treatment, inform your doctor of any pre-existing hypertension, cardiac issues, hepatic or renal impairment, or current infection-related medication. Numerous drug interactions are possible; disclose all medications to your doctor. This medication is contraindicated during pregnancy and breastfeeding due to potential fetal harm. Reliable contraception for both partners is crucial throughout treatment. Regular blood glucose monitoring may also be necessary.
Primary Ingredients of Abirawin 250 250mg
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Abirawin 250 250mg
Malignancy of the prostate gland
Major Benefits of Abirawin 250 250mg:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Administer Abirawin 250 (250mg) on an empty stomach.
Common Side effects of Abirawin 250 250mg:
- Edema (swelling)
- Vomiting
- Decreased potassium level in blood
- Fatigue
- Anemia (low number of red blood cells)
- Urinary tract infection
- Diarrhea
- High blood pressure
- Cough
- Joint swelling
How to use Abirawin 250 250mg:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer Abirawin 250 (250mg) on an empty stomach.
How Abirawin 250 250mg works:
Abirawin 250, a 250mg anticancer drug, targets prostate cancer by suppressing androgen synthesis in men. This effect is achieved through the inhibition of CYP17, a key enzyme in the male hormone production pathway, thus hindering tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Abirawin 250 250mg may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Using Abirawin 250 (250mg) during pregnancy poses a substantial risk. Pregnant women should consult their physician immediately, as research in both animals and humans indicates considerable harm to the fetus.
Breast feedingUNSAFE
Lactation and Abirawin 250 (250mg) are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by Abirawin 250 250mg.
KidneyCAUTION
For patients with severe kidney impairment, Abirawin 250 (250mg) requires careful administration. Dosage modification of Abirawin 250 (250mg) might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Abirawin 250 (250mg) cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Abirawin 250 250mg :
Omit any missed Abirawin 250 250mg dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Abirawin 250 250mg
| Label | Value |
|---|---|
| Type of Compound | Androstenedione-related compound |
| Potential for Dependence | None. |
| Type of Treatment | Cancer-fighting drugs |
